DIPG-35. BIOLOGICAL MEDICINE FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) ERADICATION: RESULTS OF THE THREE ARM BIOMARKER-DRIVEN RANDOMIZED BIOMEDE 1.0 TRIAL

Despite 50 years of clinical trials, no improvement of survival has been observed in DIPG and most children die within 2 years of diagnosis. Only radiotherapy transiently controls disease progression. The study was conceived as a randomized multi-arm multi-stage program. It started with an open-labe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Grill, Jacques, Teuff, Gwenael Le, Nysom, Karsten, Blomgren, Klas, Hargrave, Darren, MacCowage, Geoff, Bautista, Francisco, Van Vuurden, Dannis, Dangouloff-Ros, Volodia, Puget, Stephanie, Varlet, Pascale, Debily, Marie-Anne, Vassal, Gilles, Deley, Marie-Cecile Le
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Diffuse Midline Glioma/DIPG
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715776/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.083
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars